What is he best known for?
The fields of study he is best known for:
The scientist’s investigation covers issues in Fumonisin B1, Fusarium, Mycotoxin, Fumonisin and Biochemistry.
He studies Fumonisin B1, focusing on Ceramide synthase in particular.
His research integrates issues of Toxicity, Nephrotoxicity and Alkaline phosphatase in his study of Fusarium.
His Mycotoxin study incorporates themes from Chromatography, Bioassay, Microbiology and Aflatoxin.
Kenneth A. Voss interconnects Sphingosine, Apoptosis, Programmed cell death and Thin-layer chromatography in the investigation of issues within Fumonisin.
A large part of his Biochemistry studies is devoted to Sphingolipid.
His most cited work include:
- Sphingolipids - The enigmatic lipid class: Biochemistry, physiology and pathophysiology (571 citations)
- Oxidative degradation and detoxification of mycotoxins using a novel source of ozone. (278 citations)
- Sphingolipid perturbations as mechanisms for fumonisin carcinogenesis. (218 citations)
What are the main themes of his work throughout his whole career to date?
Fumonisin, Fumonisin B1, Mycotoxin, Toxicity and Fusarium are his primary areas of study.
The concepts of his Fumonisin study are interwoven with issues in Biochemistry, Carcinogen and Ceramide synthase.
Kenneth A. Voss has researched Fumonisin B1 in several fields, including Endocrinology, Urine, Internal medicine, Toxicology and Immunology.
His Mycotoxin research is multidisciplinary, incorporating elements of Toxin, Bioassay and Aflatoxin.
His Toxicity study integrates concerns from other disciplines, such as Ingestion, Necrosis, Kidney and Pharmacology.
Kenneth A. Voss combines subjects such as Nephrosis, Pathology, Nephrotoxicity and Fungi imperfecti, Microbiology with his study of Fusarium.
He most often published in these fields:
- Fumonisin (52.38%)
- Fumonisin B1 (47.62%)
- Mycotoxin (39.05%)
What were the highlights of his more recent work (between 2010-2018)?
- Fumonisin (52.38%)
- Fumonisin B1 (47.62%)
- Mycotoxin (39.05%)
In recent papers he was focusing on the following fields of study:
Kenneth A. Voss focuses on Fumonisin, Fumonisin B1, Mycotoxin, Food science and Biochemistry.
His Fumonisin research includes elements of Neural tube, Ceramide synthase and Cell biology.
His work deals with themes such as Sphingosine and Kidney, which intersect with Fumonisin B1.
His studies deal with areas such as Biomarker, Fusarium, Outbreak and Aflatoxin as well as Mycotoxin.
His Food science study combines topics from a wide range of disciplines, such as Hydrolysis, Urinary system, Urine and Toxicity.
Kenneth A. Voss works mostly in the field of Toxicity, limiting it down to topics relating to Bioassay and, in certain cases, In vivo toxicity, as a part of the same area of interest.
Between 2010 and 2018, his most popular works were:
- The kinetics of urinary fumonisin B1 excretion in humans consuming maize-based diets (57 citations)
- Human health implications from co-exposure to aflatoxins and fumonisins in maize-based foods in Latin America: Guatemala as a case study (41 citations)
- Urinary fumonisin B1 and estimated fumonisin intake in women from high- and low-exposure communities in Guatemala. (36 citations)
In his most recent research, the most cited papers focused on:
Kenneth A. Voss mainly investigates Fumonisin, Fumonisin B1, Urinary system, Urine and Food science.
His Fumonisin research incorporates elements of Ceramide synthase, Excretion and Pharmacology.
Receptor and Biochemistry are the main areas of his Ceramide synthase studies.
His Pharmacology research is multidisciplinary, incorporating perspectives in Toxicity and Mechanism of action.
The study incorporates disciplines such as Neural tube and Sphingolipid in addition to Fumonisin B1.
His Mycotoxin research incorporates themes from Aflatoxin and Co exposure.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
